New Aptiva APS IgG and APS IgM Reagents Enable Early Diagnosis of Antiphospholipid Syndrome in Hard-to-Diagnose Autoimmune Disease SAN DIEGO, Feb. 19, 2024 /PRNewswire/ — Werfen today announced it has received CE (Conformité Européenne) mark for its Aptiva® Antiphospholipid Syndrome…